Analyses were capped 7 years after PCV13 introduction because all countries contributed data for the entire 7 year period. Although all countries used PCV7 followed by PCV13 in their NIP, NIPs varied by PCV uptake, schedule (3 + 1, 2 + 1, and 3 + 0 schedules), PCV10 ...
PCV13=13-valent PCV. * California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee.19 † The 3 + 1 immunisation schedule consisted of a standard three-dose primary series at 2, 4, and 6 months of age and a booster dose at 12–15...
The ACIP and CDC changed vaccination schedule especially for those age 65 and older. Instead of a single dose Polyscharide 23 vaccine, now PCV13 ( Prevnar) is the first one to be aplied this age group and 6 to 12 months later in adition to the PCV 13 a single dose PPSV23 vaccine ...
Introduction of PCV10 into routine immunization began in Sindh, Pakistan in February 2013 with financing assistance from the GAVI Alliance. The vaccine was introduced with a 3+0 schedule, with doses given at 6, 10 and 14 weeks of life. No catch-up vaccination was offered. ...
In 2012, Ghana introduced PCV13 vaccination among children following the 3+0 vaccine dosing schedule. However, there are concerns about the 3+0 vaccine dosing schedule, as many countries that implemented this schedule have reported increased NVTs and high residual carriage of VTs [15] compared to...
There were 19 Gavi-eligible PCV-using countries with IPD surveillance eligible for PSERENADE, 13 (68.4%) of which participated, including 5 with incidence data. Of the 61 countries using a schedule with three primary doses and no booster (3 + 0), only 22 (36.1%) had eligible data, ...